Search
The American Heart Association recently issued a statement about the risk of cardiovascular disease for women with breast cancer.
Meet the Stuart family and learn why they want to revolutionize cancer treatment for people ages 15 to 39 and meet their very specific and often unmet needs.
Two second-year students -- Ellen Hukkelhoven and John Halliday -- were named Grayer Fellows for the 2010-2011 year.
An inherited mutation that contributes to lung cancer spread could be a target for therapies.
Maria Jasin, PhD, a molecular biologist at the Sloan Kettering Institute, was named a recipient of the Shaw Prize in Life Science and Medicine. Dr. Jasin was recognized for her contributions to research showing that localized double-strand breaks in DNA stimulate recombination in mammalian cells.
MSK physicians and scientists highlighted some of the institution’s latest advances in transplantation and cellular therapies at the Tandem Meetings held February 4 to 6, 2026, in Salt Lake City.
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
A number of Gerstner Sloan Kettering students working in labs across MSK have received prestigious fellowships granted by external agencies and benefactors of the school.
Memorial Sloan Kettering Cancer Center and MediSys Health Network today announced a new collaboration that will expand access to world-class cancer care for the people of Queens and eastern Brooklyn.
By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.